Hospital

To celebrate American Pharmacists Month, Pharmacy Times spoke with several pharmacists about their experiences during the COVID-19 pandemic and how they have tackled its unique challenges.

In pharmacy management, a ‘one-size-fits-all’ approach might not be the most appropriate for providing performance feedback during formal review sessions.

It is especially important to better understand the interactions between COVID-19 and acute respiratory distress syndrome.

This week’s pharmacy management Tip of the Week takes a look at establishing a clinical pharmacy site in the emergency department (ED) of a hospital.

There is a new study that discovered certain drugs cause problems in healthy people who do not have risk factors or family members with dementia.

Contrary to earlier statements from the CDC, study suggests corticosteroid inhalers used by many asthmatics might make it more difficult for COVID-19 to enter the airways.

The action is part of a growing movement to expand the ability of pharmacists and pharmacy staff to meet the needs of patients during the COVID-19 pandemic.

The goals of specialty pharmacy programs are to reduce or delay progression of the disease, improve patient outcomes, enhance patients’ quality of life, keep patients in the workforce longer, and decrease total health care costs.

Although the adverse effects of the lockdown were inevitable for cardiology patients, increased technology services may offer an opportunity for expanded patient access.

With election season intensifying, 35% of voters said drug pricing is among the most important issues influencing their vote in November.

Although researchers are testing modifications of a drug used to cure a fatal coronavirus found in cats, it shows enough action against SARS-CoV-2 to proceed to clinical trials.

Despite an ongoing long-term debate, no link was found between cancer and the use of ACE inhibitors, beta blockers, and other common antihypertensive drugs.

Millions of Americans have vision impairments and ensuring their access to websites is not only important for their health but is also a good business practice.

Investigators found that approximately 36% of the patients studied received a dosage strength of 250 mg of morphine over a 5-day period, above the CDC’s threshold for risky opioid prescribing.

A patient is experiencing severe brain fog, difficulty speaking, bilateral muscle weakness, and ataxia.

Although a study suggests that patients may show a clinical improvement when receiving a 5-day course of remdesivir, investigators said this is of uncertain clinical significance.

The US government will purchase 150 million of the new rapid COVID-19 tests in a $750 million deal with Abbott Laboratories, according to CNBC.

Although dementia-related deaths appear to be underreported overall, a study showed especially striking discrepancies for Black, male, and less educated older adults.

In an analysis, participants ages 56 and older produced neutralizing antibodies higher than those seen among patients who have recovered from COVID-19.

The Pharmacy Times® Pharmacy Focus podcast provides the latest industry news and information, thought-leader insights, clinical updates, patient counseling tools, and innovative solutions for the everyday practice and business of pharmacy.

The declaration is in response to a May CDC report, which found a concerning decrease in routine childhood immunizations during the COVID-19 pandemic.

Although the majority of survey respondents will continue using telehealth, providers must ensure the safety of their software in order to maintain patient trust.

Leaders of Operation Warp Speed optimistic for a coronavirus disease 2019 vaccine following multi-billion dollar investments in several candidates.

Improving hospital prescribing practices may reduce the risk of rehospitalization and death in older adults.

The death rate for patients who experienced a normally lower-risk heart attack rose sharply during the peak of the coronavirus disease 2019 pandemic.

Moderna will manufacture doses of its experimental coronavirus disease 2019 vaccine candidate as clinical trials are ongoing to expedite the production process.

Risdiplam is the first at-home, orally administered treatment for spinal muscular atrophy in adults and children aged 2 months and older.

Vizient report shows that the COVID-19 pandemic resulted in a $200 million increase in the top 10 COVID-related drugs, as well as a decrease in vaccinations between March and April.

The American Society of Health-System Pharmacists (ASHP) has announced that the 2020 Midyear Meeting, scheduled to be held December 6-10, 2020, will be entirely virtual.

Representatives from the organizations spoke with HHS last week before President Donald Trump signed several executive orders, including one that would address manufacturer rebates also collected by PBMs.